Scott Ganz
Biden Has a New Vaccine Goal. It’s Still Too Low.
Supply is increasing to the point that even inoculating 4 million people a day would leave tens of millions of doses unused at the beginning of June.
Could We Be Looking at a Vaccine Glut?
Soon, we’ll have enough supply to administer 4 million shots a day. We need to ramp up the processes for getting shots into arms.
Is the U.S. Holdup of the Oxford/AstraZeneca Vaccine Justified?
The clamor for its approval is understandable, but there are good reasons to ensure that it is effective enough.
The Oxford Vaccine’s True Efficacy Remains Uncertain
The preliminary results provided reason for optimism, but left many questions unanswered.
We Could Know Soon How Effective the Potential COVID Vaccines Are
The FDA’s emphasis on safety means a vaccine is months away, but we can learn before that how well they work against the virus.
A History Lesson on Ramping Up Production of Critical Goods
As companies rush to try to make needed ventilators, it’s worth revisiting efforts to make more airplanes in World War II.